David King - Ryman Healthcare Corporate Affairs Manager
| RYHTY Stock | USD 13.05 0.20 1.51% |
Executive
Mr. David King is an Corporationrationrate Affairs Manager of the company. He joined Ryman following a 21year career in journalism in New Zealand and the UK, which included editing and senior management roles. He holds a Bachelor of Arts and a Journalism Certifi cate. since 2013.
| Tenure | 11 years |
| Phone | 64 3 366 4069 |
| Web | https://www.rymanhealthcare.co.nz |
David King Latest Insider Activity
Tracking and analyzing the buying and selling activities of David King against Ryman Healthcare pink sheet is an integral part of due diligence when investing in Ryman Healthcare. David King insider activity provides valuable insight into whether Ryman Healthcare is net buyers or sellers over its current business cycle. Note, Ryman Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ryman Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David King over a week ago Disposition of 537 shares by David King of Williams Sonoma subject to Rule 16b-3 |
Ryman Healthcare Management Efficiency
Ryman Healthcare's management efficiency ratios could be used to measure how well Ryman Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Bridget Sherick | Select Medical Holdings | N/A | |
| Nasser MD | Acadia Healthcare | N/A | |
| Kirk Cheney | Pennant Group | N/A | |
| RN BSN | Enhabit | 66 | |
| Mark Palmenter | Acadia Healthcare | N/A | |
| Heather CPA | Acadia Healthcare | 52 | |
| Kim Sullivan | Encompass Health Corp | N/A | |
| Rebecca Orcutt | ModivCare | 38 | |
| Benjamin Adams | InnovAge Holding Corp | 60 | |
| Matt Huray | InnovAge Holding Corp | N/A | |
| Barbara CPA | ModivCare | 60 | |
| Nathan Vaughn | ModivCare | N/A | |
| Cara Babachicos | InnovAge Holding Corp | N/A | |
| Dylan Black | Enhabit | 54 | |
| Andrew Price | Encompass Health Corp | 57 | |
| Isa Diaz | Acadia Healthcare | N/A | |
| Jing Zhang | Concord Medical Services | 49 | |
| MS DO | Encompass Health Corp | 64 | |
| FACP MD | InnovAge Holding Corp | 57 | |
| Lynette CPA | Pennant Group | 47 | |
| Henry Toledo | ModivCare | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 |
Ryman Healthcare Leadership Team
Elected by the shareholders, the Ryman Healthcare's board of directors comprises two types of representatives: Ryman Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryman. The board's role is to monitor Ryman Healthcare's management team and ensure that shareholders' interests are well served. Ryman Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryman Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Claire Higgins, Non-Executive Independent Director | ||
| Anthony Leighs, Independent Director | ||
| Cameron Holland, Chief Australia | ||
| Richard Umbers, Group Exec | ||
| Gordon MacLeod, CFO, Deputy Chief Executive and Company Secretary | ||
| Kevin Hickman, Co-Founder, Director and Member of Remuneration and Nominations Committee | ||
| Taylor Allison, Design Manager | ||
| Michelle Perkins, IR Contact Officer | ||
| Simon Challies, CEO, Managing Director, Executive Director | ||
| Tom Brownrigg, Construction Manager | ||
| Jo Appleyard, Independent Non-Executive Director | ||
| Jenn Poskitt, Marketing Manager | ||
| Philip Mealings, Property and Purchasing Manager | ||
| George Savvides, Independent Director | ||
| Douglas McKay, Independent Director | ||
| Cheyne Chalmers, Chief Zealand | ||
| Debbie McClure, Group Sales Manager | ||
| Warren Bell, Independent Non-Executive Director | ||
| David Bennett, Group Officer | ||
| Deborah Marris, G Sec | ||
| Marsha Cadman, Chief Officer | ||
| Rick Davies, Chief Officer | ||
| Andrew Mitchell, Development Manager | ||
| David Kerr, Independent Non-Executive Chairman of the Board | ||
| Geoffrey Cumming, Director | ||
| MaryAnne Stone, Chief Officer | ||
| David King, Corporate Affairs Manager | ||
| Chris BE, Chief Officer | ||
| Barbara ReynenRose, Operations & Clinical Services Manager | ||
| Nicole Forster, Group Shared Services Manager |
Ryman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ryman Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.91 B | |||
| Shares Outstanding | 100 M | |||
| Price To Earning | 10.13 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 3.74 X | |||
| Revenue | 503.76 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ryman Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ryman Healthcare's short interest history, or implied volatility extrapolated from Ryman Healthcare options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryman Healthcare Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Ryman Pink Sheet analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |